Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 18/20 | 0.63 |
| ▸ | HTR1D | P28221 | 16/20 | 0.63 |
| ▸ | HTR1B | P28222 | 12/20 | 0.63 |
| ▸ | DRD2 | P14416 | 2/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.62 |
| ▸ | HTR2B | P41595 | 2/20 | 0.62 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.62 |
| ▸ | HTR7 | P34969 | 1/20 | 0.62 |
| ▸ | DRD3 | P35462 | 1/20 | 0.62 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4184483 | 0.99 | HTR1A (0.62) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| Hydrochloric Acid SCHEMBL4195586 | 0.99 | HTR1A (0.62) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| SCHEMBL13927811 | 0.92 | HTR1D (0.55) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| Hydrochloric Acid SCHEMBL4189920 | 0.92 | HTR1D (0.55) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| SCHEMBL13927809 | 0.91 | HTR1D (0.55) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| Hydrochloric Acid SCHEMBL4182874 | 0.90 | HTR1D (0.54) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| SCHEMBL4185004 | 0.90 | HTR1A (0.63) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| SCHEMBL4189977 | 0.89 | DRD2 (0.63) | HTR1AHTR1DHTR1BDRD2HTR2A | |
| SCHEMBL4195524 | 0.85 | HTR1D (0.57) | HTR1AHTR1DHTR1BDRD2SLC6A4 | |
| SCHEMBL4198528 | 0.85 | HTR1D (0.57) | HTR1AHTR1DHTR1BDRD2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090042874-A1 | ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS | WYETH (US) | 2009-02-12 | — | — | US | disclosed |
| US-20090042874-A1 | ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS | WYETH (US) | 2009-02-12 | — | — | US | disclosed |
| US-20090042874-A1 | ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS | WYETH (US) | 2009-02-12 | — | — | US | disclosed |
| WO-2008150848-A1 | ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS | WYETH (US) | 2008-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042874-A1 | ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS | HTR5A, CRH, CYP17A1 | HTR1A 77/4885HTR1D 80/4885HTR1B 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.